Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2022
Clear all
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20225 results available
- October 20221 results available
- September 20227 results available
- August 202215 results available
- July 20225 results available
- June 202211 results available
- May 20225 results available
- April 20225 results available
- March 202211 results available
- February 20226 results available
- January 20227 results available
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 78 items.
Gas cylinders containing commercial grade oxygen instead of medical grade oxygen were delivered to homecare customers.
RecallHealth product recall | 2022-12-22
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
OCALIVA received a Notice of Compliance with Conditions in May 2017 for the treatment of PBC, pending the results of trials to verify its clinical benefit.
OCALIVA is now contraindicated for PBC patients with advanced disease, such as those with Child…
AlertHealth professional risk communication | 2022-12-05
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
Since earlier this year, supplies of various formats of non-prescription pediatric/infant and children’s acetaminophen and ibuprofen products have been limited in retail and pharmacy locations and hospitals across Canada. This shortage is due to…
AlertPublic advisory | 2022-10-07
Potential for a future out of specification result during shelf-life
RecallHealth product recall | 2022-09-28
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406.
RecallHealth product recall | 2022-09-22
Out of Specification result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
Out of specification result for Spheroids Dissolution Rate Profile (DRP)
RecallHealth product recall | 2022-09-21
Health Canada inspectors seized counterfeit Nuceiva (Prabotulinumtoxin A) from a New You Spa location in Vaughan, Ontario (Unit 5, 60 Winges Road). Nuceiva is botulinum toxin type A prescription drug that is administered by injection for the temporary…
AlertPublic advisory | 2022-09-06
The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
Out of specification result for assay test in the affected lots
RecallHealth product recall | 2022-08-31
Affected lot may contain particulate matter
RecallHealth product recall | 2022-08-30